Abvc BIOPHARMA, Inc. (ABVC) intrinsic value & 10-year financials
Abvc BIOPHARMA, Inc. (ABVC) has a Graham intrinsic value of $0.66 per share. At $0.92 on Oct 17, 2026, the stock trades 39% above that value. Over the last 10 fiscal years revenue grew 70.9% a year to $296.0K, with an average return on invested capital of -420.5%.
- Graham intrinsic value
- $0.66
- Share price (Oct 17, 2026)
- $0.92
- Price vs Graham value
- 39% above
- Market cap
- $18.5M
- Revenue (FY2025)
- $296.0K
- Revenue growth (10-yr CAGR)
- 70.9%
- ROIC (10-yr avg)
- -420.5%
- Free cash flow (FY2025)
- —
ABVC 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $296.0K | -$7.9M | -$0.39 | — | -2416.0% | -96.4% |
| FY2024 | $0 | -$4.9M | -$0.42 | — | — | -78.7% |
| FY2023 | $152.4K | -$10.5M | -$2.43 | -$4.3M | -5390.3% | -107.2% |
| FY2022 | $969.8K | -$16.4M | -$0.50 | -$7.5M | -1558.5% | -263.3% |
| FY2021 | $355.8K | -$12.0M | -$0.51 | -$7.6M | -3290.1% | -291.5% |
| FY2020 | $483.0K | -$10.6M | -$0.50 | — | -1760.9% | -405.5% |
| FY2019 | $701.7K | -$3.9M | — | — | -492.9% | 223.8% |
| FY2018 | $7.0K | -$4.1M | -$0.02 | — | -20034.7% | 28.5% |
| FY2017 | — | -$4.2M | -$0.02 | — | — | 505.9% |
| FY2016 | — | -$4.5M | $0.02 | — | — | -3720.4% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
ABVC BIOPHARMA, INC. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
ABVC BIOPHARMA, INC. has historically struggled to out-earn its cost of capital, averaging just -29.3% ROIC.
Over the decade, ABVC BIOPHARMA, INC. shows that management has aggressively returned capital to shareholders by retiring 89.6% of outstanding shares.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, ABVC BIOPHARMA, INC. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $0.66 per share.